{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:45:15Z","timestamp":1791402315221,"version":"4.3.3"},"reference-count":190,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T00:00:00Z","timestamp":1684022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005402","name":"Dasman Diabetes Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005402","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.mam.2023.101190","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T13:28:05Z","timestamp":1684330085000},"page":"101190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Antifungal prophylaxis and pre-emptive therapy: When and how?"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2457-6437","authenticated-orcid":false,"given":"Rosanne","family":"Sprute","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia A.","family":"Nacov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionysios","family":"Neofytos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Oliverio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Prattes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Reinhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannik","family":"Stemler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mam.2023.101190_bib1","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.healun.2018.06.008","article-title":"Clinical risk factors for invasive aspergillosis in lung transplant recipients: results of an international cohort study","volume":"37","author":"Aguilar","year":"2018","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.mam.2023.101190_bib2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1469-0691.2010.03289.x","article-title":"Invasive fungal infections in congenital immunodeficiencies","volume":"16","author":"Antachopoulos","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.mam.2023.101190_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010080","article-title":"Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence","volume":"5","author":"Arendrup","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2023.101190_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13623","article-title":"Candida infections in solid organ transplantation: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Aslam","year":"2019","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.mam.2023.101190_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/cid\/ciz156","article-title":"Invasive fungal infection after lung transplantation: epidemiology in the setting of antifungal prophylaxis","volume":"70","author":"Baker","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2019.104021","article-title":"Raw genome sequence data for 13 isogenic Aspergillus fumigatus strains isolated over a 2 year period from a patient with chronic granulomatous disease","volume":"25","author":"Ballard","year":"2019","journal-title":"Data Brief"},{"key":"10.1016\/j.mam.2023.101190_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/lt.24365","article-title":"Efficacy and cost-effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high-risk liver transplant recipients","volume":"22","author":"Balogh","year":"2016","journal-title":"Liver Transplant."},{"key":"10.1016\/j.mam.2023.101190_bib8","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the intensive care unit working group","volume":"72","author":"Bassetti","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib9","first-page":"307","article-title":"Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome","volume":"183","author":"Benedetti","year":"1996","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.mam.2023.101190_bib10","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11908-013-0380-y","article-title":"Anti-Aspergillus prophylaxis in lung transplantation: a systematic review and meta-analysis","volume":"15","author":"Bhaskaran","year":"2013","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.mam.2023.101190_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1086\/321811","article-title":"Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey","volume":"33","author":"Blumberg","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib12","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1093\/mmy\/myab025","article-title":"Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients","volume":"59","author":"Bogler","year":"2021","journal-title":"Med. Mycol."},{"key":"10.1016\/j.mam.2023.101190_bib13","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/cid\/ciaa358","article-title":"Isavuconazole as primary antifungal prophylaxis in patients with acute myeloid leukemia or myelodysplastic syndrome: an open-label, prospective, phase 2 study","volume":"72","author":"Bose","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF02114892","article-title":"Risk factors for systemic fungal infections in liver transplant recipients","volume":"14","author":"Briegel","year":"1995","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib15","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/00007890-199602270-00029","article-title":"Incidence and significance of Aspergillus cultures following liver and kidney transplantation","volume":"61","author":"Brown","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.mam.2023.101190_bib16","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/14787210.2021.1855143","article-title":"CAR-T cell therapy and infection: a review","volume":"19","author":"Bupha-Intr","year":"2021","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.mam.2023.101190_bib17","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1016\/j.transproceed.2005.10.043","article-title":"Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients","volume":"37","author":"Castroagudin","year":"2005","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.mam.2023.101190_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/imj.13668","article-title":"Pneumocystis jirovecii pneumonia in patients with acute myeloid leukaemia","volume":"48","author":"Chang","year":"2018","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.mam.2023.101190_bib19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijantimicag.2015.02.023","article-title":"Aerosolised liposomal amphotericin B to prevent aspergillosis in acute myeloid leukaemia: efficacy and cost effectiveness in real-life","volume":"46","author":"Chong","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.mam.2023.101190_bib20","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10096-013-2027-1","article-title":"Multidrug-resistant endemic clonal strain of Candida auris in India","volume":"33","author":"Chowdhary","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00277-020-04297-8","volume":"100","author":"Christopeit","year":"2021","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.mam.2023.101190_bib22","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00277-021-04452-9","volume":"100","author":"Classen","year":"2021","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.mam.2023.101190_bib23","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/597395","article-title":"Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial","volume":"48","author":"Cordonnier","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib24","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.3324\/haematol.2010.038463","article-title":"Voriconazole as secondary antifungal prophylaxis in stem cell transplant recipients","volume":"96","author":"Cordonnier","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.mam.2023.101190_bib25","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 7","key":"10.1016\/j.mam.2023.101190_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.mam.2023.101190_bib27","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1128\/AAC.04569-14","article-title":"Safety and pharmacokinetics of isavuconazole as antifungal prophylaxis in acute myeloid leukemia patients with neutropenia: results of a phase 2, dose escalation study","volume":"59","author":"Cornely","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mam.2023.101190_bib28","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/jac\/dkx133","article-title":"Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia","volume":"72","author":"Cornely","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mam.2023.101190_bib29","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European confederation of medical mycology in cooperation with the mycoses study group education and research consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib30","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/myc.12960","article-title":"Defining breakthrough invasive fungal infection-Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology","volume":"62","author":"Cornely","year":"2019","journal-title":"Mycoses"},{"key":"10.1016\/j.mam.2023.101190_bib31","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib32","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/00003246-199906000-00019","article-title":"Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients","volume":"27","author":"Eggimann","year":"1999","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.mam.2023.101190_bib33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/ajt.12993","article-title":"Targeted versus universal antifungal prophylaxis among liver transplant recipients","volume":"15","author":"Eschenauer","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.mam.2023.101190_bib34","article-title":"Hospital outbreak of fluconazole-resistant Candida parapsilosis: arguments for clonal transmission and long-term persistence","author":"Fekkar","year":"2021","journal-title":"Antimicrob. Agents Chemother. 2023;95(5):e02036-20. doi:10.1128\/AAC.02036-20"},{"key":"10.1016\/j.mam.2023.101190_bib35","doi-asserted-by":"crossref","first-page":"1242 e11","DOI":"10.1016\/j.amjmed.2014.07.010","article-title":"Incidence of Pneumocystis jiroveci pneumonia among groups at risk in HIV-negative patients","volume":"127","author":"Fillatre","year":"2014","journal-title":"Am. J. Med."},{"key":"10.1016\/j.mam.2023.101190_bib36","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/323129","article-title":"Prevention of infection caused by Pneumocystis carinii in transplant recipients","volume":"33","author":"Fishman","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib37","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13587","article-title":"Pneumocystis jiroveci in solid organ transplantation: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Fishman","year":"2019","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.mam.2023.101190_bib38","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMoa2016272","article-title":"Dasatinib\u2013blinatumomab for ph-positive acute lymphoblastic leukemia in adults","volume":"383","author":"Fo\u00e0","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2023.101190_bib39","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1053\/jlts.2002.36239","article-title":"Risk factors for invasive aspergillosis in liver transplant recipients","volume":"8","author":"Fortun","year":"2002","journal-title":"Liver Transplant."},{"key":"10.1016\/j.mam.2023.101190_bib40","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/TP.0b013e3181932e76","article-title":"Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients","volume":"87","author":"Fortun","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.mam.2023.101190_bib41","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13101529","article-title":"Candida glabrata antifungal resistance and virulence factors, a perfect pathogenic combination","volume":"13","author":"Frias-De-Leon","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mam.2023.101190_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140930","article-title":"Meta-Analysis and cost comparison of empirical versus pre-emptive antifungal strategies in hematologic malignancy patients with high-risk febrile neutropenia","volume":"10","author":"Fung","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2023.101190_bib44","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa021931","article-title":"Itraconazole to prevent fungal infections in chronic granulomatous disease","volume":"348","author":"Gallin","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2023.101190_bib45","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","article-title":"Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study","volume":"10","author":"Gangneux","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.mam.2023.101190_bib46","article-title":"Invasive fungal infections after anti-CD19 chimeric antigen receptor-modified T-cell therapy: state of the evidence and future directions","volume":"7","author":"Garner","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.mam.2023.101190_bib47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1086\/430602","article-title":"Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study","volume":"41","author":"Gavalda","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib48","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bbmt.2014.03.004","article-title":"Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO)","volume":"20","author":"Girmenia","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.mam.2023.101190_bib49","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/j.ejca.2008.06.040","article-title":"Empirical antifungal therapy for patients with neutropenia and persistent fever: systematic review and meta-analysis","volume":"44","author":"Goldberg","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.mam.2023.101190_bib50","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2023.101190_bib51","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1086\/515126","article-title":"Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued?","volume":"28","author":"Gordon","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib52","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.4065\/82.9.1052","article-title":"Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials","volume":"82","author":"Green","year":"2007","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.mam.2023.101190_bib53","first-page":"CD005590","article-title":"Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients","author":"Green","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.mam.2023.101190_bib54","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/cpdd.284","article-title":"Pharmacokinetic assessment of drug-drug interactions of isavuconazole with the immunosuppressants cyclosporine, mycophenolic acid, prednisolone, sirolimus, and tacrolimus in healthy adults","volume":"6","author":"Groll","year":"2017","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.mam.2023.101190_bib55","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1093\/jac\/dkac098","article-title":"Comment on: nephrotoxicity of continuous amphotericin B in critically ill patients with abdominal sepsis: a retrospective analysis with propensity score matching","volume":"77","author":"Grothe","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mam.2023.101190_bib56","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jtct.2021.04.019","article-title":"Early versus late fluconazole prophylaxis in autologous hematopoietic cell transplantation","volume":"27","author":"Guarana","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.mam.2023.101190_bib57","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/1078155208101959","article-title":"Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients","volume":"15","author":"Harnicar","year":"2009","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.mam.2023.101190_bib58","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13054-021-03753-9","article-title":"Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study","volume":"25","author":"Hatzl","year":"2021","journal-title":"Crit. Care"},{"key":"10.1016\/j.mam.2023.101190_bib59","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s00277-017-3098-3","article-title":"Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)","volume":"96","author":"Heinz","year":"2017","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.mam.2023.101190_bib60","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.2019004000","article-title":"How I prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies","volume":"136","author":"Hill","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.mam.2023.101190_bib61","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1016\/S1473-3099(20)30784-2","volume":"21","author":"Hoenigl","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib62","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s40265-021-01611-0","article-title":"The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin","volume":"81","author":"Hoenigl","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.mam.2023.101190_bib63","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/s41564-022-01172-2","article-title":"COVID-19-associated fungal infections","volume":"7","author":"Hoenigl","year":"2022","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.mam.2023.101190_bib64","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1080\/13543784.2022.2086120","article-title":"Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of action","volume":"31","author":"Hoenigl","year":"2022","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.mam.2023.101190_bib65","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1097\/TP.0000000000000743","article-title":"The effectiveness of culture-directed preemptive anti-Aspergillus treatment in lung transplant recipients at one year after transplant","volume":"99","author":"Hosseini-Moghaddam","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.mam.2023.101190_bib66","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13544","article-title":"Invasive aspergillosis in solid-organ transplant recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Husain","year":"2019","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.mam.2023.101190_bib67","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/j.1600-6143.2006.01548.x","article-title":"Voriconazole prophylaxis in lung transplant recipients","volume":"6","author":"Husain","year":"2006","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.mam.2023.101190_bib68","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.healun.2018.02.006","article-title":"A strategy for prevention of fungal infections in lung transplantation: role of bronchoalveolar lavage fluid galactomannan and fungal culture","volume":"37","author":"Husain","year":"2018","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.mam.2023.101190_bib69","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/jof1030293","article-title":"Pneumocystis pneumonia in solid-organ transplant recipients","volume":"1","author":"Iriart","year":"2015","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.mam.2023.101190_bib70","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/ajt.12947","article-title":"Risk factors of Pneumocystis pneumonia in solid organ recipients in the era of the common use of posttransplantation prophylaxis","volume":"15","author":"Iriart","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.mam.2023.101190_bib71","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1093\/infdis\/jiaa394","article-title":"Core recommendations for antifungal stewardship: a statement of the mycoses study group education and research consortium","volume":"222","author":"Johnson","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib72","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1200\/JCO.19.01916","article-title":"D-index-guided early antifungal therapy versus empiric antifungal therapy for persistent febrile neutropenia: a randomized controlled noninferiority trial","volume":"38","author":"Kanda","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mam.2023.101190_bib73","doi-asserted-by":"crossref","first-page":"E544","DOI":"10.1111\/ctr.12016","article-title":"Variable magnitude of drug interaction between oral voriconazole and cyclosporine A in recipients of allogeneic hematopoietic stem cell transplantation","volume":"26","author":"Kikuchi","year":"2012","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.mam.2023.101190_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2014.08.011","article-title":"Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006-2008)","volume":"21","author":"Klingspor","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.mam.2023.101190_bib76","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijantimicag.2016.10.019","article-title":"Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study","volume":"49","author":"Koehler","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.mam.2023.101190_bib77","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkz051","article-title":"Development and validation of the European QUALity (EQUAL) score for mucormycosis management in haematology","author":"Koehler","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mam.2023.101190_bib78","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.cmi.2019.04.031","article-title":"Intensive care management of influenza-associated pulmonary aspergillosis","volume":"25","author":"Koehler","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"issue":"10","key":"10.1016\/j.mam.2023.101190_bib75","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.cmi.2019.04.024","article-title":"Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis","volume":"25","author":"Koehler","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.mam.2023.101190_bib79","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib80","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/infdis\/166.6.1379","article-title":"Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation","volume":"166","author":"Kusne","year":"1992","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib81","doi-asserted-by":"crossref","unstructured":"Lamoth, F., Lewis, R.E., Walsh, T.J., Kontoyiannis, D.P., 2021. Navigating the uncertainties of COVID-19 associated aspergillosis (CAPA): a comparison with influenza associated aspergillosis (IAPA). J Infect Dis. 2021;224(10):1631-1640. doi:10.1093\/infdis\/jiab163.","DOI":"10.1093\/infdis\/jiab163"},{"key":"10.1016\/j.mam.2023.101190_bib82","doi-asserted-by":"crossref","first-page":"O952","DOI":"10.1111\/1469-0691.12688","article-title":"Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study","volume":"20","author":"Lerolle","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.mam.2023.101190_bib83","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13613-015-0103-7","article-title":"Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study","volume":"6","author":"Leroy","year":"2016","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.mam.2023.101190_bib84","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jmii.2015.01.002","article-title":"Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation","volume":"49","author":"Liu","year":"2016","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.mam.2023.101190_bib85","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00939-18","article-title":"Inability to culture Pneumocystis jirovecii","volume":"9","author":"Liu","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.mam.2023.101190_bib86","doi-asserted-by":"crossref","first-page":"110","DOI":"10.37201\/req\/094.2019","article-title":"Use of micafungin as antifungal prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) in Spain (GETH-MIC)","volume":"33","author":"L\u00f3pez-S\u00e1nchez","year":"2020","journal-title":"Rev. Espa\u00f1ola Quimioter."},{"key":"10.1016\/j.mam.2023.101190_bib87","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1469-0691.2011.03548.x","article-title":"Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007)","volume":"17","author":"Lortholary","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.mam.2023.101190_bib88","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s15010-020-01521-5","article-title":"Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper","volume":"49","author":"Los-Arcos","year":"2021","journal-title":"Infection"},{"key":"10.1016\/j.mam.2023.101190_bib89","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/01.TP.0000437434.42851.d4","article-title":"Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis","volume":"97","author":"Luong","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.mam.2023.101190_bib90","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1182\/blood.V97.6.1604","article-title":"Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation","volume":"97","author":"Maertens","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.mam.2023.101190_bib91","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/496927","article-title":"Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study","volume":"41","author":"Maertens","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.mam.2023.101190_bib95","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/cid\/ciac623","article-title":"Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer","volume":"76","author":"Maertens","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mam.2023.101190_bib92","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.mam.2023.101190_bib93","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1093\/jac\/dkw157","article-title":"ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Maertens","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mam.2023.101190_bib94","first-page":"3221","article-title":"European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia","volume":"73","author":"Maertens","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mam.2023.101190_bib96","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/422993","article-title":"Long-term interferon-gamma therapy for patients with chronic granulomatous disease","volume":"39","author":"Marciano","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib97","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1080\/10428194.2016.1204652","article-title":"Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 study","volume":"58","author":"Mariette","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.mam.2023.101190_bib98","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-2141.2011.08838.x","article-title":"Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation","volume":"155","author":"Marks","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mam.2023.101190_bib99","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood.V96.6.2055","article-title":"Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial","volume":"96","author":"Marr","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.mam.2023.101190_bib100","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood-2002-05-1496","article-title":"Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors","volume":"100","author":"Marr","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.mam.2023.101190_bib101","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1182\/blood-2003-08-2644","article-title":"Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants","volume":"103","author":"Marr","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.mam.2023.101190_bib102","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00134-016-4578-y","article-title":"Increased incidence of co-infection in critically ill patients with influenza","volume":"43","author":"Martin-Loeches","year":"2017","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.mam.2023.101190_bib103","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00134-019-05599-w","article-title":"ESICM\/ESCMID task force on practical management of invasive candidiasis in critically ill patients","volume":"45","author":"Martin-Loeches","year":"2019","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.mam.2023.101190_bib104","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2015.0460","article-title":"Clinical implications of globally emerging azole resistance in Aspergillus fumigatus","volume":"371","author":"Meis","year":"2016","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.mam.2023.101190_bib105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00277-017-3196-2","article-title":"Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)","volume":"97","author":"Mellinghoff","year":"2018","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.mam.2023.101190_bib106","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11046-017-0115-y","article-title":"Risk factors and outcomes of invasive fungal infections in allogeneic hematopoietic cell transplant recipients","volume":"182","author":"Miceli","year":"2017","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mam.2023.101190_bib107","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/bmt.2009.38","article-title":"Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients","volume":"44","author":"Mori","year":"2009","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.mam.2023.101190_bib108","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1439-0507.2011.02158.x","article-title":"Adverse interactions between antifungal azoles and vincristine: review and analysis of cases","volume":"55","author":"Moriyama","year":"2012","journal-title":"Mycoses"},{"key":"10.1016\/j.mam.2023.101190_bib109","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality","volume":"49","author":"Morrell","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mam.2023.101190_bib110","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1399-3062.2010.00492.x","article-title":"Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients","volume":"12","author":"Neofytos","year":"2010","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib111","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.diagmicrobio.2012.10.001","article-title":"Epidemiology, outcomes, and risk factors of invasive fungal infections in adult patients with acute myelogenous leukemia after induction chemotherapy","volume":"75","author":"Neofytos","year":"2013","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib112","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12898","article-title":"Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study","volume":"20","author":"Neofytos","year":"2018","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib113","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12984","article-title":"Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort","volume":"20","author":"Neofytos","year":"2018","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib114","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-6143.2010.03375.x","article-title":"Antifungal prophylaxis in lung transplantation--a world-wide survey","volume":"11","author":"Neoh","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.mam.2023.101190_bib115","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s15010-021-01625-6","article-title":"Multiple organ failure might be an indication for prophylactic antifungal therapy in acute pancreatitis","volume":"49","author":"Ning","year":"2021","journal-title":"Infection"},{"key":"10.1016\/j.mam.2023.101190_bib116","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/lt.21099","article-title":"Risk factors for invasive aspergillosis in living donor liver transplant recipients","volume":"13","author":"Osawa","year":"2007","journal-title":"Liver Transplant."},{"key":"10.1016\/j.mam.2023.101190_bib117","first-page":"1068","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study","volume":"91","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.mam.2023.101190_bib118","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2016.09.002","article-title":"Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations","volume":"31","author":"Pagano","year":"2017","journal-title":"Blood Rev."},{"issue":"Suppl. 6","key":"10.1016\/j.mam.2023.101190_bib119","doi-asserted-by":"crossref","first-page":"S379","DOI":"10.1086\/429329","article-title":"Amphotericin B lipid complex in the treatment of invasive fungal infections: results of the Collaborative Exchange of Antifungal Research (CLEAR), an industry-supported patient registry","volume":"40","author":"Pappas","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib120","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1600-6143.2005.01176.x","article-title":"Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study","volume":"6","author":"Pappas","year":"2006","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.mam.2023.101190_bib121","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib122","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib123","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/cid\/cis599","article-title":"The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial","volume":"55","author":"Park","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib124","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00005792-199903000-00003","article-title":"Invasive aspergillosis in transplant recipients","volume":"78","author":"Paterson","year":"1999","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.mam.2023.101190_bib125","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib126","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13630","article-title":"Antifungal prophylaxis in lung transplant: a survey of United States' transplant centers","volume":"33","author":"Pennington","year":"2019","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.mam.2023.101190_bib127","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1097\/01.CCM.0000147726.62304.7F","article-title":"Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients","volume":"32","author":"Piarroux","year":"2004","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.mam.2023.101190_bib128","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4187\/respcare.04128","article-title":"Safety and efficiency of percutaneous dilatational tracheostomy with direct bronchoscopic guidance for thoracic transplant recipients","volume":"61","author":"Pilarczyk","year":"2016","journal-title":"Respir. Care"},{"key":"10.1016\/j.mam.2023.101190_bib129","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1200\/JCO.2008.21.0856","article-title":"Index to predict invasive mold infection in high-risk neutropenic patients based on the area over the neutrophil curve","volume":"27","author":"Portugal","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mam.2023.101190_bib130","article-title":"Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology","author":"Prattes","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.mam.2023.101190_bib131","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s00134-021-06471-6","article-title":"Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry","volume":"47","author":"Prattes","year":"2021","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.mam.2023.101190_bib132","article-title":"Fungal infections in hematopoietic stem-cell transplant patients: a review of epidemiology, diagnosis, and management","volume":"8","author":"Rahi","year":"2021","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.mam.2023.101190_bib133","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/586739","article-title":"Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial","volume":"46","author":"Rijnders","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib134","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1067\/mcp.2002.121911","article-title":"Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients","volume":"71","author":"Romero","year":"2002","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.mam.2023.101190_bib135","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12897","article-title":"Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"20","author":"Rosillo","year":"2018","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib136","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/ejh.13372","article-title":"Bridging antifungal prophylaxis with 50 mg or 100 mg micafungin in allogeneic stem cell transplantation: a retrospective analysis","volume":"104","author":"Rothe","year":"2020","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.mam.2023.101190_bib137","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13054-021-03874-1","article-title":"Invasive pulmonary aspergillosis among intubated patients with SARS-CoV-2 or influenza pneumonia: a European multicenter comparative cohort study","volume":"26","author":"Rouze","year":"2022","journal-title":"Crit. Care"},{"key":"10.1016\/j.mam.2023.101190_bib138","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2165\/00003495-200868140-00002","article-title":"Patients at high risk of invasive fungal infections: when and how to treat","volume":"68","author":"R\u00fcping","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.mam.2023.101190_bib139","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13613-020-00686-4","article-title":"COVID-19-associated invasive pulmonary aspergillosis","volume":"10","author":"Rutsaert","year":"2020","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.mam.2023.101190_bib140","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jiac.2016.05.006","article-title":"An overview of infectious complications after allogeneic hematopoietic stem cell transplantation","volume":"22","author":"Sahin","year":"2016","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.mam.2023.101190_bib141","doi-asserted-by":"crossref","first-page":"E454","DOI":"10.1111\/ctr.12129","article-title":"Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era","volume":"27","author":"Saliba","year":"2013","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.mam.2023.101190_bib142","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/13693786.2012.701765","article-title":"Outcomes associated with amphotericin B lipid complex (ABLC) prophylaxis in high-risk liver transplant patients","volume":"51","author":"Saliba","year":"2013","journal-title":"Med. Mycol."},{"key":"10.1016\/j.mam.2023.101190_bib143","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/cid\/ciu1128","article-title":"Randomized trial of micafungin for the prevention of invasive fungal infection in high-risk liver transplant recipients","volume":"60","author":"Saliba","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib144","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3201\/eid2704.204895","article-title":"COVID-19-Associated pulmonary aspergillosis, march-august 2020","volume":"27","author":"Salmanton-Garcia","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib145","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.mam.2023.101190_bib146","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s15010-006-5113-9","article-title":"A prospective, randomized multicenter trial of the empirical addition of antifungal therapy for febrile neutropenic cancer patients: results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II","volume":"34","author":"Schiel","year":"2006","journal-title":"Infection"},{"key":"10.1016\/j.mam.2023.101190_bib147","first-page":"3654","article-title":"Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial","volume":"93","author":"Schwartz","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.mam.2023.101190_bib148","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/MOH.0b013e32834115e7","article-title":"Advances in the diagnosis and treatment of chronic granulomatous disease","volume":"18","author":"Seger","year":"2011","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.mam.2023.101190_bib149","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00134-009-1405-8","article-title":"Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients","volume":"35","author":"Senn","year":"2009","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.mam.2023.101190_bib150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00268-005-7807-z","article-title":"Early presumptive therapy with fluconazole for occult Candida infection after gastrointestinal surgery","volume":"30","author":"Shan","year":"2006","journal-title":"World J. Surg."},{"key":"10.1016\/j.mam.2023.101190_bib151","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/13693780701200372","article-title":"Fungal infections in solid organ transplantation","volume":"45","author":"Silveira","year":"2007","journal-title":"Med. Mycol."},{"issue":"Suppl. 4","key":"10.1016\/j.mam.2023.101190_bib152","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/ajt.12114","article-title":"Candida infections in solid organ transplantation","volume":"13","author":"Silveira","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.mam.2023.101190_bib153","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1086\/345441","article-title":"Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients","volume":"36","author":"Singh","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib154","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study","volume":"171","author":"Slavin","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib155","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00134-021-06603-y","article-title":"Inhaled amphotericin B lipid complex for prophylaxis against COVID-19-associated invasive pulmonary aspergillosis","volume":"48","author":"Soriano","year":"2022","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.mam.2023.101190_bib156","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/myc.13205","article-title":"Epidemiology of invasive fungal disease in haematologic patients","volume":"64","author":"Souza","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.mam.2023.101190_bib157","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jinf.2012.08.003","article-title":"Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry","volume":"65","author":"Steinbach","year":"2012","journal-title":"J. Infect."},{"key":"10.1016\/j.mam.2023.101190_bib158","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00277-020-04107-1","article-title":"Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma","volume":"99","author":"Stemler","year":"2020","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.mam.2023.101190_bib159","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/myc.13039","article-title":"Risk factors and mortality in invasive Rasamsonia spp. infection: analysis of cases in the FungiScope(\u00ae) registry and from the literature","volume":"63","author":"Stemler","year":"2020","journal-title":"Mycoses"},{"key":"10.1016\/j.mam.2023.101190_bib160","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1016\/S2352-3026(22)00073-4","article-title":"Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association","volume":"9","author":"Stemler","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.mam.2023.101190_bib161","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkad143","article-title":"Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)","author":"Stemler","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mam.2023.101190_bib162","article-title":"Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients","volume":"2014","author":"Stern","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.mam.2023.101190_bib163","article-title":"Infectious complications of CAR T-cell therapy: a clinical update","volume":"8","author":"Stewart","year":"2021","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.mam.2023.101190_bib164","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/TP.0b013e31829d674f","article-title":"Micafungin versus amphotericin B lipid complex for the prevention of invasive fungal infections in high-risk liver transplant recipients","volume":"96","author":"Sun","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.mam.2023.101190_bib165","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1016\/j.ijid.2011.01.011","article-title":"Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study","volume":"15","author":"Tan","year":"2011","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib166","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2165\/00003088-200645070-00002","article-title":"Pharmacokinetic\/pharmacodynamic profile of voriconazole","volume":"45","author":"Theuretzbacher","year":"2006","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.mam.2023.101190_bib167","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00007890-199501150-00009","article-title":"Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study","volume":"59","author":"Tollemar","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.mam.2023.101190_bib168","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.mam.2023.101190_bib169","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/bmt.2009.345","article-title":"Tacrolimus use in adult allogeneic stem cell transplant recipients receiving voriconazole: preemptive dose modification and therapeutic drug monitoring","volume":"45","author":"Trifilio","year":"2010","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.mam.2023.101190_bib170","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2023.101190_bib171","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00277-016-2711-1","article-title":"Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016","volume":"95","author":"Ullmann","year":"2016","journal-title":"Ann. Hematol."},{"issue":"Suppl. 1","key":"10.1016\/j.mam.2023.101190_bib172","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.mam.2023.101190_bib173","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13054-021-03728-w","article-title":"Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis\/aspergillus tracheobronchitis","volume":"25","author":"Van Ackerbroeck","year":"2021","journal-title":"Crit. Care"},{"key":"10.1016\/j.mam.2023.101190_bib174","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1164\/rccm.202004-1038LE","article-title":"COVID-19-associated pulmonary aspergillosis","volume":"202","author":"van Arkel","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.mam.2023.101190_bib175","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/422312","article-title":"Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation","volume":"39","author":"van Burik","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2023.101190_bib176","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/17425255.2020.1764939","article-title":"Posaconazole in prophylaxis and treatment of invasive fungal infections: a pharmacokinetic, pharmacodynamic and clinical evaluation","volume":"16","author":"Van Daele","year":"2020","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.mam.2023.101190_bib177","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00134-021-06431-0","article-title":"Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial","volume":"47","author":"Vanderbeke","year":"2021","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.mam.2023.101190_bib178","first-page":"103","article-title":"Delphi-based study and analysis of key risk factors for invasive fungal infection in haematological patients","volume":"30","author":"V\u00e1zquez","year":"2017","journal-title":"Rev. Espa\u00f1ola Quimioter."},{"key":"10.1016\/j.mam.2023.101190_bib179","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMoa040446","article-title":"Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia","volume":"351","author":"Walsh","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2023.101190_bib180","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/jac\/dkt369","article-title":"Identification of factors influencing the pharmacokinetics of voriconazole and the optimization of dosage regimens based on Monte Carlo simulation in patients with invasive fungal infections","volume":"69","author":"Wang","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mam.2023.101190_bib181","article-title":"Does high-dose cytarabine cause more fungal infection in patients with acute myeloid leukemia undergoing consolidation therapy: a multicenter, prospective, observational study in China","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.mam.2023.101190_bib182","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00134-012-2673-2","article-title":"Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study","volume":"38","author":"Wauters","year":"2012","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.mam.2023.101190_bib183","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/phar.2433","article-title":"Incidence of viral and fungal complications after utilization of alternative donor sources in hematopoietic cell transplantation","volume":"40","author":"Whited","year":"2020","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.mam.2023.101190_bib184","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","article-title":"Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation","volume":"116","author":"Wingard","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.mam.2023.101190_bib185","doi-asserted-by":"crossref","first-page":"729","DOI":"10.7326\/0003-4819-131-10-199911160-00003","article-title":"Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial","volume":"131","author":"Winston","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.mam.2023.101190_bib186","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1111\/ajt.12963","article-title":"Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients","volume":"14","author":"Winston","year":"2014","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.mam.2023.101190_bib187","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11046-009-9188-6","article-title":"Current approaches in antifungal prophylaxis in high risk hematologic malignancy and hematopoietic stem cell transplant patients","volume":"168","author":"Wirk","year":"2009","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mam.2023.101190_bib188","first-page":"15","article-title":"Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study","volume":"6","author":"Wissing","year":"2013","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.mam.2023.101190_bib189","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3324\/haematol.2019.229781","article-title":"Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)","volume":"105","author":"Yakoub-Agha","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.mam.2023.101190_bib190","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12185-017-2224-2","article-title":"Primary fungal prophylaxis in acute leukemia patients with different risk factors: retrospective analysis from the CAESAR study","volume":"106","author":"Zhang","year":"2017","journal-title":"Int. J. Hematol."}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299723000304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299723000304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T18:19:18Z","timestamp":1758824358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299723000304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":190,"alternative-id":["S0098299723000304"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2023.101190","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antifungal prophylaxis and pre-emptive therapy: When and how?","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2023.101190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101190"}}